Stocksigma LogoStocksigma Logo

Vilin Bio Med Reports H1 FY27 Results with Strong Revenue Growth

Vilin Bio Med reported standalone revenue from operations of ₹3,260.00 lakhs for the half-year ended 30th Sep'26, jumping 237.33% YoY from ₹966.40 lakhs

Vilin Bio Med Reports H1 FY27 Results with Strong Revenue Growth

Vilin Bio Med Ltd · Outcome · 14 Nov 2026, 10:49 pm

Vilin Bio Med Reports H1 FY27 Results with Strong Revenue Growth Vilin Bio Med reported standalone revenue from operations of ₹3,260.00 lakhs for the half-year ended 30th Sep'26, jumping 237.33% YoY from ₹966.40 lakhs. Standalone net profit surged to ₹128.16 lakhs versus ₹15.17 lakhs in the previous corresponding period, driving EPS up to ₹0.84 from ₹0.11 YoY. On a consolidated basis, net profit stood at ₹127.86 lakhs. The company fully utilized its ₹338.00 lakhs preferential issue proceeds raised on 4th Mar'26 primarily for working capital (₹327.00 lakhs) with zero deviations.

Original exchange filing (PDF)

More announcements from Vilin Bio Med Ltd

All Vilin Bio Med Ltd announcements